ELV Elevance Health

• $2.2M bought by 3 insiders
• $6.4M sold by 5 insiders outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. Mark Kaye CFO
   Sale
   $4.7M 10,584 shares at $440.13 35% of stake
   Traded Oct 22 Filed Oct 23
   ↗
3. Gail Boudreaux CEO
   Buy
   $1M 2,725 shares at $367.79 +1.6% to stake
   Traded Jul 17 Filed Jul 17
   ↗
4. Ramiro G Peru Director
   Buy
   $366K 1,000 shares at $366.05 +10% to stake
   Traded Jul 17 Filed Jul 17
   ↗
5. Ronald W Penczek CAO & Controller
   Sale
   $149K 369 shares at $403.16 9% of stake
   Traded Jun 12 Filed Jun 15
   ↗
6. Robert L Dixon Jr. Director
   Sale
   $61K 151 shares at $401.77 1.4% of stake
   Traded Jun 11 Filed Jun 12
   ↗
7. Ronald W Penczek CAO & Controller
   Sale
   $617K 1,531 shares at $403.13 27% of stake
   Traded May 19 Filed May 20
   ↗
8. Amy W Schulman Director
   Sale
   $7,475 26 shares at $287.50 11% of stake
   Traded Mar 12 Filed Mar 23
   ↗
9. Charles Morgan Kendrick Jr. EVP & President, Commercial
   Sale
   $911K 3,196 shares at $284.92 21% of stake
   Traded Mar 6 Filed Mar 9
   ↗
10. Steven H Collis Director
    Buy
    $870K 3,000 shares at $289.84 +470% to stake
    Traded Mar 5 Filed Mar 6
    ↗

Also filed in the last 12 months, not counted as buying or selling: 28 stock grants, 22 share withholdings for taxes, and 2 option exercises.